Inventor · disambiguated record
Volker Seibert
Also filed as: SEIBERT VOLKER
14 granted patents·12 pending applications·64 citations·filing 2004–2023
91Inventor score
Top patents by PatentIndex Score
26 records- 0197US10836830B2Antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Nov 17, 2020·12 cites·45 claims
- 0296US10626181B2Nucleic acids encoding anti-OX40 antibodiesAGENUS INC·Filed 2019·Granted Apr 21, 2020·7 cites·35 claims
- 0396US10280226B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2018·Granted May 7, 2019·17 cites·30 claims
- 0496US10155818B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2015·Granted Dec 18, 2018·17 cites·4 claims
- 0588US10800849B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2018·Granted Oct 13, 2020·2 cites·26 claims
- 0687US10577426B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2018·Granted Mar 3, 2020·3 cites·21 claims
- 0785US11472883B2Methods of administering anti-OX40 antibodiesAGENUS INC·Filed 2020·Granted Oct 18, 2022·1 cites·15 claims
- 0884US11447557B2Antibodies and methods of use thereofAGENUS INC·Filed 2016·Granted Sep 20, 2022·3 cites·46 claims
- 0984US11136404B2Anti-OX40 antibodiesAGENUS INC·Filed 2019·Granted Oct 5, 2021·1 cites·64 claims
- 1084US10829559B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2019·Granted Nov 10, 2020·1 cites·8 claims
- 1184US2023167186A1Methods of administering anti-ox40 antibodiesAGENUS INC·Filed 2022·Application pending·0 cites
- 1284US2023108348A1Methods of administering anti-ox40 antibodiesAGENUS INC·Filed 2022·Application pending·0 cites
- 1382US2023039577A1Anti-gitr antibodies and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 1480US2023406946A1Antibodies and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 1580US2023399413A1Antibodies and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 1679US2022098316A1Anti-ox40 antibodies and methods of use thereofAGENUS INC·Filed 2021·Application pending·0 cites
- 1775US11897962B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Feb 13, 2024·0 cites·11 claims
- 1873US11401335B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Aug 2, 2022·0 cites·16 claims
- 1972US2021171648A1Antibodies and methods of use thereofAGENUS INC·Filed 2020·Application pending·0 cites
- 2067US2021324097A1Anti-ox40 antibodies and methods of use thereofAGENUS INC·Filed 2021·Application pending·0 cites
- 2164US2024102044A1T cell receptors that bind to ny-eso-1 and methods of use thereofMINK THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2261US11613764B2T cell receptors that bind to NY-ESO-1 and methods of use thereofMINK THERAPEUTICS INC·Filed 2019·Granted Mar 28, 2023·0 cites·8 claims
- 2355US2020079862A1Anti-ox40 antibodies and methods of use thereofAGENUS INC·Filed 2016·Application pending·0 cites
- 2444US11898165B2Engineered host cells and methods of use thereofMINK THERAPEUTICS INC·Filed 2016·Granted Feb 13, 2024·0 cites·12 claims
- 2541US2020123265A1Anti-gitr antibodies and methods of use thereofAGENUS INC·Filed 2016·Application pending·0 cites
- 2635US2009252721A1Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancerBUSCHMANN THOMAS·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Volker Seibert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →